Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $37.33 million. The enterprise value is $80.81 million.
| Market Cap | 37.33M |
| Enterprise Value | 80.81M |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, before market open.
| Earnings Date | Aug 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 60.21 million shares outstanding.
| Shares Outstanding | 60.21M |
| Owned by Insiders (%) | 5.56% |
| Owned by Institutions (%) | 43.20% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.12 |
| PS Ratio | 0.13 |
| Forward PS | 0.02 |
| PB Ratio | 0.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.71 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.83 |
Financial Efficiency
Return on equity (ROE) is -7.30% and return on invested capital (ROIC) is -4.56%.
| Return on Equity (ROE) | -7.30% |
| Return on Assets (ROA) | -3.90% |
| Return on Capital (ROIC) | -4.56% |
| Revenue Per Employee | $353,822 |
| Profits Per Employee | -$29,950 |
| Employee Count | 839 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.23 |
Taxes
In the past 12 months, Zepp Health has paid $1.30 million in taxes.
| Income Tax | 1.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.80% in the last 52 weeks. The beta is 0.77, so Zepp Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -46.80% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.11 |
| Relative Strength Index (RSI) | 31.83 |
| Average Volume (20 Days) | 90,282 |
Short Selling Information
| Short Interest | 3,126 |
| Short Previous Month | 23,400 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, Zepp Health had revenue of $296.86 million and -$25.13 million in losses. Loss per share was -$0.40.
| Revenue | 296.86M |
| Gross Profit | 90.86M |
| Operating Income | -23.37M |
| Pretax Income | -23.59M |
| Net Income | -25.13M |
| EBITDA | n/a |
| EBIT | -17.43M |
| Loss Per Share | -$0.40 |
Balance Sheet
The company has $137.30 million in cash and $180.78 million in debt, giving a net cash position of -$43.49 million or -$0.72 per share.
| Cash & Cash Equivalents | 137.30M |
| Total Debt | 180.78M |
| Net Cash | -43.49M |
| Net Cash Per Share | -$0.72 |
| Equity (Book Value) | 331.22M |
| Book Value Per Share | 5.50 |
| Working Capital | 113.56M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.61%, with operating and profit margins of -7.87% and -8.46%.
| Gross Margin | 30.61% |
| Operating Margin | -7.87% |
| Pretax Margin | -7.95% |
| Profit Margin | -8.46% |
| EBITDA Margin | n/a |
| EBIT Margin | -5.87% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.87% |
| Shareholder Yield | -5.87% |
| Earnings Yield | -67.32% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zepp Health has an Altman Z-Score of 0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 |
| Piotroski F-Score | 3 |